Isto Biologics

Isto Biologics

Private
Hopkinton, MassachusettsHealthcare & Life Scienceshttps://www.istobiologics.com/

Last Round

Buyout/LBO

Sep 17, 2025

Est. Valuation

$1B

Total Funding Raised

$37.8M

Company Overview

Isto Biologics is a biotechnology company that manufactures orthobiologic medical devices, including autologous concentration systems, allografts, and biosynthetic bone grafts, for use in spine, orthopedics, and sports medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

orthobiologicsbone graftautologous therapyplatelet-rich plasmaPRPregenerative medicinesurgical biologicsallograftbone graft substitutespine surgerymedical devicemedtechconcentrated bone marrow aspiratecBMAspinal fusionsports medicineautologous concentration system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Isto Biologics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Isto Biologics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOSep 17, 2025
M&AOct 25, 2023
Buyout/LBOJun 3, 2016
DebtMar 18, 2014
Growth EquityOct 25, 2007
Series E
Aug 1, 2007

Isto Biologics Investors

Notable investors and investment history

InvestorRounds
DW Healthcare PartnersGrowth Equity
EQT Life SciencesSeries E, Series D
Mid-America Transplant ServicesSeries E, Series D
Thompson Street Capital PartnersBuyout/LBO, M&A
Keensight CapitalBuyout/LBO
Alafi CapitalSeries E, Series D
Ascension VenturesSeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 17, 2025

    $1.0B round led by Keensight Capital

  • Oct 25, 2023

    Funded by Thompson Street Capital Partners.

Isto Biologics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Isto Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Isto Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHopkinton, Massachusetts
Employee Range13
Year Founded1997
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.